| Vitamin A1, 2 | Vitamin D ** | Vitamin E5 | Vitamin K | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unit | μg/day (RAE) | IU/day (RAE) | μg/day 4 | IU/day 4 | mg/day | μg/day | |||||||||||
| EAR | RDA/AI | UL3 | EAR | RDA/AI | UL3 | EAR | RDA/AI | UL | EAR | RDA/AI | UL | EAR | RDA/AI | UL6 | AI | UL7 | |
| Infants | |||||||||||||||||
| 0-6 mo | ND | 400* | 600 | ND | 1333* | 2000 | ND | 10* | 25 | ND | 400* | 1000 | ND | 4* | ND | 2.0* | ND |
| 7-12 mo | ND | 500* | 600 | ND | 1667* | 2000 | ND | 10* | 38 | ND | 400* | 1500 | ND | 5* | ND | 2.5* | ND |
| Children | |||||||||||||||||
| 1-3 y | 210 | 300 | 600 | 700 | 1000 | 2000 | 10 | 15 | 63 | 400 | 600 | 2500 | 5 | 6 | 200 | 30* | ND |
| 4-8 y | 275 | 400 | 900 | 917 | 1333 | 3000 | 10 | 15 | 75 | 400 | 600 | 3000 | 6 | 7 | 300 | 55* | ND |
| Males | |||||||||||||||||
| 9-13 y | 445 | 600 | 1700 | 1483 | 2000 | 5667 | 10 | 15 | 100 | 400 | 600 | 4000 | 9 | 11 | 600 | 60* | ND |
| 14-18 y | 630 | 900 | 2800 | 2100 | 3000 | 9333 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 800 | 75* | ND |
| 19-30 y | 625 | 900 | 3000 | 2083 | 3000 | 10000 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 1000 | 120* | ND |
| 31-50 y | 625 | 900 | 3000 | 2083 | 3000 | 10000 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 1000 | 120* | ND |
| 51-70 y | 625 | 900 | 3000 | 2083 | 3000 | 10000 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 1000 | 120* | ND |
| >70 y | 625 | 900 | 3000 | 2083 | 3000 | 10000 | 10 | 20 | 100 | 400 | 800 | 4000 | 12 | 15 | 1000 | 120* | ND |
| Females | |||||||||||||||||
| 9-13 y | 420 | 600 | 1700 | 1400 | 2000 | 5667 | 10 | 15 | 100 | 400 | 600 | 4000 | 9 | 11 | 600 | 60* | ND |
| 14-18 y | 485 | 700 | 2800 | 1617 | 2333 | 9333 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 800 | 75* | ND |
| 19-30 y | 500 | 700 | 3000 | 1667 | 2333 | 10000 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 1000 | 90* | ND |
| 31-50 y | 500 | 700 | 3000 | 1667 | 2333 | 10000 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 1000 | 90* | ND |
| 51-70 y | 500 | 700 | 3000 | 1667 | 2333 | 10000 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 1000 | 90* | ND |
| >70 y | 500 | 700 | 3000 | 1667 | 2333 | 10000 | 10 | 20 | 100 | 400 | 800 | 4000 | 12 | 15 | 1000 | 90* | ND |
| Pregnancy | |||||||||||||||||
| < 18 y | 530 | 750 | 2800 | 1767 | 2500 | 9333 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 800 | 75* | ND |
| 19-30 y | 550 | 770 | 3000 | 1833 | 2567 | 10000 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 1000 | 90* | ND |
| 31-50 y | 550 | 770 | 3000 | 1833 | 2567 | 10000 | 10 | 15 | 100 | 400 | 600 | 4000 | 12 | 15 | 1000 | 90* | ND |
| Lactation | |||||||||||||||||
| < 18 y | 885 | 1200 | 2800 | 2950 | 4000 | 9333 | 10 | 15 | 100 | 400 | 600 | 4000 | 16 | 19 | 800 | 75* | ND |
| 19-30 y | 900 | 1300 | 3000 | 3000 | 4333 | 10000 | 10 | 15 | 100 | 400 | 600 | 4000 | 16 | 19 | 1000 | 90* | ND |
| 31-50 y | 900 | 1300 | 3000 | 3000 | 4333 | 10000 | 10 | 15 | 100 | 400 | 600 | 4000 | 16 | 19 | 1000 | 90* | ND |
|
This table presents Estimated Average Requirements (EARs) in italics, Recommended Dietary Allowances (RDAs) in bold type and Adequate Intakes (AIs) in ordinary type followed by an asterisk (*). Tolerable Upper Intake Levels (ULs) are in shaded columns. ** New 2010 values have replaced previous 1997 values. 1 As Retinol Activity Equivalents (RAE). See conversion factors for more details. 2 No DRIs are established for beta-carotene or other carotenoids. However, existing recommendations for consumption of carotenoid-rich fruits and vegetables are supported. 3 UL as preformed vitamin A only. Beta-carotene supplements are advised only to serve as a provitamin A source for individuals at risk of vitamin A deficiency. 4 These reference values assume minimal sun exposure. 5 EAR and RDA/AI as alpha-tocopherol (2R-stereoisomeric forms) only. See conversion factors for more details. 6 The UL for vitamin E applies only to synthetic vitamin E (all isomeric forms) obtained from supplements, fortified foods, or a combination of the two. 7 Due to lack of suitable data, a UL could not be established for vitamin K. This does not mean that there is no potential for adverse effects resulting from high intakes. Note: These are reference values for normal, apparently healthy individuals eating a typical mixed North American diet. An individual may have physiological, health, or lifestyle characteristics that may require tailoring of specific nutrient values. |
|||||||||||||||||
| Vitamin C8 | Thiamin | Riboflavin | Niacin 10 | Vitamin B6 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unit | mg/day | mg/day | mg/day | mg/day (NE) | mg/day | ||||||||||
| EAR | RDA/AI | UL | EAR | RDA/AI | UL9 | EAR | RDA/AI | UL9 | EAR | RDA/AI | UL11 | EAR | RDA/AI | UL | |
| Infants | |||||||||||||||
| 0-6 mo 7-12 mo |
ND ND |
40* 50* |
ND ND |
ND ND |
0.2* 0.3* |
ND ND |
ND ND |
0.3* 0.4* |
ND ND |
ND ND |
2*a 4* |
ND ND |
ND ND |
0.1* 0.3* |
ND ND |
| Children | |||||||||||||||
| 1-3 y 4-8 y |
13 22 |
15 25 |
400 650 |
0.4 0.5 |
0.5 0.6 |
ND ND |
0.4 0.5 |
0.5 0.6 |
ND ND |
5 6 |
6 8 |
10 15 |
0.4 0.5 |
0.5 0.6 |
30 40 |
| Males | |||||||||||||||
| 9-13 y 14-18 y 19-30 y 31-50 y 51-70 y >70 y |
39 63 75 75 75 75 |
45 75 90 90 90 90 |
1200 1800 2000 2000 2000 2000 |
0.7 1.0 1.0 1.0 1.0 1.0 |
0.9 1.2 1.2 1.2 1.2 1.2 |
ND ND ND ND ND ND |
0.8 1.1 1.1 1.1 1.1 1.1 |
0.9 1.3 1.3 1.3 1.3 1.3 |
ND ND ND ND ND ND |
9 12 12 12 12 12 |
12 16 16 16 16 16 |
20 30 35 35 35 35 |
0.8 1.1 1.1 1.1 1.4 1.4 |
1.0 1.3 1.3 1.3 1.7 1.7 |
60 80 100 100 100 100 |
| Females | |||||||||||||||
| 9-13 y 14-18 y 19-30 y 31-50 y 51-70 y >70 y |
39 56 60 60 60 60 |
45 65 75 75 75 75 |
1200 1800 2000 2000 2000 2000 |
0.7 0.9 0.9 0.9 0.9 0.9 |
0.9 1.0 1.1 1.1 1.1 1.1 |
ND ND ND ND ND ND |
0.8 0.9 0.9 0.9 0.9 0.9 |
0.9 1.0 1.1 1.1 1.1 1.1 |
ND ND ND ND ND ND |
9 11 11 11 11 11 |
12 14 14 14 14 14 |
20 30 35 35 35 35 |
0.8 1.0 1.1 1.1 1.3 1.3 |
1.0 1.2 1.3 1.3 1.5 1.5 |
60 80 100 100 100 100 |
| Pregnancy | |||||||||||||||
| < 18 y 19-30 y 31-50 y |
66 70 70 |
80 85 85 |
1800 2000 2000 |
1.2 1.2 1.2 |
1.4 1.4 1.4 |
ND ND ND |
1.2 1.2 1.2 |
1.4 1.4 1.4 |
ND ND ND |
14 14 14 |
18 18 18 |
30 35 35 |
1.6 1.6 1.6 |
1.9 1.9 1.9 |
80 100 100 |
| Lactation | |||||||||||||||
| < 18 y 19-30 y 31-50 y |
96 100 100 |
115 120 120 |
1800 2000 2000 |
1.2 1.2 1.2 |
1.4 1.4 1.4 |
ND ND ND |
1.3 1.3 1.3 |
1.6 1.6 1.6 |
ND ND ND |
13 13 13 |
17 17 17 |
30 35 35 |
1.7 1.7 1.7 |
2.0 2.0 2.0 |
80 100 100 |
|
This table presents Estimated Average Requirements (EARs) in italics, Recommended Dietary Allowances (RDAs) in bold type and Adequate Intakes (AIs) in ordinary type followed by an asterisk (*). Tolerable Upper Intake Levels (ULs) are in shaded columns. 8 Because smoking increases oxidative stress and metabolic turnover of vitamin C, the requirement for smokers is increased by 35 mg/day. 9 Due to lack of suitable data, ULs could not be established for thiamin and riboflavin. This does not mean that there is no potential for adverse effects resulting from high intakes. 10 As Niacin Equivalents (NE). See conversion factors for more details. 11 The UL for niacin applies only to synthetic forms obtained from supplements, fortified foods, or a combination of the two. a As preformed niacin, not NE, for this age group. Note: These are reference values for normal, apparently healthy individuals eating a typical mixed North American diet. An individual may have physiological, health, or lifestyle characteristics that may require tailoring of specific nutrient values. |
|||||||||||||||
| Folate12 | Vitamin B12 | Pantothenic Acid | Biotin | Choline15 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unit | μg/day (DFE) | μg/day | mg/day | μg/day | mg/day | |||||||
| EAR | RDA/AI | UL13 | EAR | RDA/AI | UL14 | AI | UL14 | AI | UL14 | AI | UL | |
| Infants | ||||||||||||
| 0-6 mo 7-12 mo |
ND ND |
65* 80* |
ND ND |
ND ND |
0.4* 0.5* |
ND ND |
1.7* 1.8* |
ND ND |
5* 6* |
ND ND |
125* 150* |
ND ND |
| Children | ||||||||||||
| 1-3 y 4-8 y |
120 160 |
150 200 |
300 400 |
0.7 1.0 |
0.9 1.2 |
ND ND |
2* 3* |
ND ND |
8* 12* |
ND ND |
200* 250* |
1000 1000 |
| Males | ||||||||||||
| 9-13 y 14-18 y 19-30 y 31-50 y 51-70 y >70 y |
250 330 320 320 320 320 |
300 400 400 400 400 400 |
600 800 1000 1000 1000 1000 |
1.5 2.0 2.0 2.0 2.0 2.0 |
1.8 2.4 2.4 2.4 2.4 d 2.4 d |
ND ND ND ND ND ND |
4* 5* 5* 5* 5* 5* |
ND ND ND ND ND ND |
20* 25* 30* 30* 30* 30* |
ND ND ND ND ND ND |
375* 550* 550* 550* 550* 550* |
2000 3000 3500 3500 3500 3500 |
| Females | ||||||||||||
| 9-13 y 14-18 y 19-30 y 31-50 y 51-70 y >70 y |
250 330 320 320 320 320 |
300 400b 400b 400b 400 400 |
600 800 1000 1000 1000 1000 |
1.5 2.0 2.0 2.0 2.0 2.0 |
1.8 2.4 2.4 2.4 2.4d 2.4 d |
ND ND ND ND ND ND |
4* 5* 5* 5* 5* 5* |
ND ND ND ND ND ND |
20* 25* 30* 30* 30* 30* |
ND ND ND ND ND ND |
375* 400* 425* 425* 425* 425* |
2000 3000 3500 3500 3500 3500 |
| Pregnancy | ||||||||||||
| < 18 y 19-30 y 31-50 y |
520 520 520 |
600c 600c 600c |
800 1000 1000 |
2.2 2.2 2.2 |
2.6 2.6 2.6 |
ND ND ND |
6* 6* 6* |
ND ND ND |
30* 30* 30* |
ND ND ND |
450* 450* 450* |
3000 3500 3500 |
| Lactation | ||||||||||||
| < 18 y 19-30 y 31-50 y |
450 450 450 |
500 500 500 |
800 1000 1000 |
2.4 2.4 2.4 |
2.8 2.8 2.8 |
ND ND ND |
7* 7* 7* |
ND ND ND |
35* 35* 35* |
ND ND ND |
550* 550* 550* |
3000 3500 3500 |
|
This table presents Estimated Average Requirements (EARs) in italics, Recommended Dietary Allowances (RDAs) in bold type and Adequate Intakes (AIs) in ordinary type followed by an asterisk (*). Tolerable Upper Intake Levels (ULs) are in shaded columns. 12 As Dietary Folate Equivalents (DFE). See conversion factors for more details. 13 The UL for folate applies only to synthetic forms obtained from supplements, fortified foods, or a combination of the two. 14 Due to lack of suitable data, ULs could not be established for vitamin B12, pantothenic acid or biotin. This does not mean that there is no potential for adverse effects resulting from high intakes. 15 Although AIs have been set for choline, there are few data to assess whether a dietary supply of choline is needed at all stages of the life cycle, and it may be that the choline requirement can be met by endogenous synthesis at some of these stages. b In view of evidence linking the use of supplements containing folic acid before conception and during early pregnancy with reduced risk of neural tube defects in the fetus, it is recommended that all women capable of becoming pregnant take a supplement containing 400μg of folic acid every day, in addition to the amount of folate found in a healthy diet. c It is assumed that women will continue consuming 400 μg folic acid from supplements until their pregnancy is confirmed and they enter prenatal care. The critical time for formation of the neural tube is shortly after conception. d Because 10 to 30 percent of older people may malabsorb food-bound vitamin B12, it is advisable for those older than 50 years to meet the RDA mainly by consuming foods fortified with vitamin B12 or a supplement containing vitamin B12. Note: These are reference values for normal, apparently healthy individuals eating a typical mixed North American diet. An individual may have physiological, health, or lifestyle characteristics that may require tailoring of specific nutrient values. |
||||||||||||